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Figure 1. HTDV/HERV-K Expression
(A) HTDV/HERV-K particles expressed in human teratocarcinoma cells. Ultrathin section, (B) immunolabeling with goat anti HERV-K Gag
antibody in ultrathin frozen section (right). Bar represents 250 nm. (C) HERV-K mRNA expression in human tissues. Steady state levels of
HERV-K mRNA were revealed by hybridizations of commercially available Northern blots (Clontech). Lane 1, spleen; 2, thymus; 3, prostate;
4, testis; 5, ovary; 6, small intestine; 7, colon; 8, primary blood mononuclear cells (PBMC). Probes: radiolabeled HERV-K env probe (upper
panel, ToÈ njes et al., 1997) and actin probe (lower panel). Arrow indicates full-length transcripts.
locus. If the 100-fold increase in RT activity in the islet levels in a panel of diabetes patients and healthy blood
donors with the primers described by Conrad et al. (lo-supernatant described by Conrad et al. had originated
from the presence of viral particles, one would have cated exclusively in the 39LTR) and with HERV-K-spe-
cific primers designed to amplify other regions of theexpected a similar accumulation of the matching viral
genome as in HTDV particles. The lack of such a specific genome, especially the env gene. In this study no differ-
ence was observed in the prevalence of HERV-K plasmaenrichment may indicate that the collected material, al-
though banding at the density of a retrovirus, merely RNA in IDDM patients (n 5 14, of which 9 were of recent
onset) versus healthy blood donors (n 5 12).contains polyribosomes or nucleoproteins associated
with a variety of diverse endogenous retrovirus tran- The failure to assign specific HERV-K expression to
diabetes patients is not unexpected as we have foundscripts.
In addition, there is no real proof that an IDDMK1,222 that full-length and even spliced transcripts of this en-
dogenous retrovirus family are present at low level in aprovirus exists at all. In the multistep, nested PCR ap-
proach to clone IDDMK1,222, only the primer in the R variety of normal tissues including lymphocytes (see
Figure 1). Taking into account that during the onset ofregion of the 39LTR used to amplify the 39 part of the
genome is specific for IDDMK1,222- or K18-like provi- diabetes autoreactive T cells are activated, an early rise
in plasma RNA level could merely reflect increased num-ruses. The 59 part may be derived from any other provirus
as the primers will amplify many HTDV/HERV-K se- bers of decaying cells. However, because no differences
in patients versus healthy controls were detected, anquences. It is not clear from the publication whether a
full-length cDNA had been the template for IDDMK1,222 additional quantitative RT-PCR approach was not per-
formed.or whether this sequence was generated using the over-
lapping 59 and 39 amplicons as templates. The latter The primers used by Conrad et al. for the epidemiolog-
ical study are located in highly conserved parts of theprocedure most probably would have resulted in a mo-
saic element. As no controls for the RT-PCR reactions U3 and R regions as judged from the many LTR se-
quences we have studied so far. Thus, they are notare shown, the template for the entire procedure may
also have been contaminating DNA. Thus, IDDMK1,222 specific for the IDDMK1,222 sequence in contrast to the
R primer used to clone the 39 part of the genome.may be identical to the K18 provirus or it may turn out
to be a composite sequence due to the cloning proce- The Lack of Disease-Specific HERV-K Expression
Is Paralleled by the Lack of Disease-Specificdure. At the moment, only portions of the sequence are
published or deposited in the databases. Even if the HERV-K Antibodies
Although the action of a superantigen may not necessar-IDDMK1,222 provirus would code for an RT protein, an
enzymatic activity remains speculative until demon- ily correlate with the induction of a humoral immune
response to viral structural proteins, the presence ofstrated.
In summary, the data presented by no means exclude virus particles as indicated by Conrad et al. certainly
would do so. More than 40 sera collected from patientsthat the RT activity detected in the IDDM supernatants
originated from HTDV/HERV-K proviruses other than with IDDM have been tested for HERV-K-specific anti-
bodies using the following test systems: (a) immunofluo-IDDMK1,222 or from other HERV families. LINE elements
expressed in T cell lines are another likely source for rescence staining of a virus-producing teratocarcinoma
cell line, (b) Western blot analyses using virus particlethe RT activity.
Occurrence of HERV-K RNA Is Not Confined preparations or recombinant Env protein as antigen, and
(c) ELISA reactivity against diagnostic synthetic Gag andto or Elevated in Diabetes Patients
Taking precautions not to amplify contaminating DNA, Env peptides. All these test systems are routinely used
to screen panels of sera from diverse groups of patientswe repeated the epidemiological study of plasma RNA
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and healthy blood donors. Among these we usually see recently reported similar results using human and mu-
rine test systems (Symposium on ªRetroviruses and Au-3% reactivity in normal blood donors with tests (a) and
toimmunity,º 1998, London). However, murine A20 cells(c) (Boller et al., 1997). The same rate of reactivity is
transiently transfected with the IDDMK1,222-related ex-detected in IDDM patients, yet there is no concordance
pression clone did not stimulate corresponding BALB/cof results between the test systems. Using recombinant
T cells in a Vb-specific fashion while A20 cells trans-Env protein as antigen in Western blots (ToÈ njes et al.,
fected with an MMTV superantigen induced a Vb14-1997), we detect a higher percentage of positive reac-
selective expansion of T cells. Truncating the longer Envtions (20%±25%) in both IDDM patients and healthy
sequence to the size of IDDMK1,222 did not alter thecontrols. Similar results have been reported with differ-
negative result.ent panels of patient sera (Vogetseder et al., 1993). In
Clearly, further studies including more HTDV/HERV-Ksummary, these findings are in agreement with the ob-
sequences as well as the expression clone establishedservation that HERV-K plasma RNA levels are similar in
by Conrad et al. are needed to either confirm or refuteIDDM and healthy blood donors and raise the question
the hypothesis that a superantigen is encoded by thiswhether the antibody reactions are based on the expres-
HERV family. If the superantigen exists, its involvementsion of HERV-K proteins or are induced by a cross-
in the onset or progression of insulin-dependent diabe-reacting antigen of unknown origin. Remarkably, the
tes mellitus needs to be examined. With regard to otheranti-Env Western blot reactivity detected in IDDM pa-
bacterial and especially viral superantigens, it seemstients and healthy controls is not associated with a cor-
very unlikely that the sequence published by Conrad etresponding reactivity to Gag proteins, again arguing
al. would be unique amongst all HTDV/HERV-K provi-against the presence of virus particles.
ruses in encoding a superantigen.In contrast, with all the test systems used an antibody
response with high titers is consistently detected in ap-
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6 of 12 control subjects had evidence of the IDDMK1,222-ToÈ njes, R.R., Limbach, C., LoÈ wer, R., and Kurth, R. (1997). J. Virol.
like env RNA sequences in the plasma (Figure 1B) with-71, 2747±2756.
out demonstrable contaminating genomic DNA (FigureVogetseder, W., Dumfahrt, A., Mayersbach, P., Schonitzer, D., and
1C). This RT-PCR study suggests that HERV-K viremiaDierich, M.P. (1993). K. AIDS Res. Hum. Retroviruses 9, 687±694
appears to be a common human occurrence but not aWeissmahr, R.N., BoÈ ni, J., and SchuÈ pbach, J. (1997). J. Virol. 71,
3005±3012 finding specifically associated with the onset of type 1
diabetes.
In further studies, we cloned the IDDMK1,222 env from
peripheral blood genomic DNA of a patient with typeHERV-K10s and Immune-Mediated
1 diabetes and sequenced 38 clones amplified using(Type 1) Diabetes
PCR primers complementary to the putative IDDMK1,222
env gene. A family of seven (RIC1 to -7) closely related
Immune-mediated (type 1) diabetes is a multigenetic, HERV-K10-like sequences were found suggesting that
autoimmune disease that is environmentally influenced, several HERV-K10-like sequences similar to IDDMK1,222
with worldwide incidence rates that vary greatly (Atkin- are present in the human genome. All of the sequences
son and Maclaren, 1994). Whereas the inductive events show high degrees of homology with that of HERV-
remain speculative, a viral etiology has been frequently K10 with identical sequences between IDDMK1,222
implicated (Maclaren and Atkinson, 1997). Conrad and and RIC1 (GenBank accession numbers: AF084864,
colleagues have proposed that the pancreatic b cell AF084865, AF086866, AF086867, AF086868, AF086869,
damage is mediated by autoreactive T lymphocytes and AF086870). Our findings, taken together with those
activated systemically by a retroviral superantigen (Sag). of Conrad et al., rather strongly suggest that IDDMK1,222
This hypothesis is based on three observations: the should be considered to be one of the multiple variants
enrichment of Vb7 in the receptor repertoires expressed of HERV-K10 rather than a specific entity. On the nucleo-
by T lymphocytes in the pancreas of two recently diag- tide level, there is greater than 90% homology between
nosed diabetic patients (Conrad et al., 1994); the sub- HERV-K10 and IDDMK1,222 env gene. The amino acid
sequent cloning of a superantigen encoded by the en- variability of the env and pol sequences of HERV-K10,
velope (env) gene of a species of the endogenous and the IDDMK1,222 is less than 5% (Conrad et al., 1997)
retrovirus HERV-K10 (IDDMK1,222); and the demonstra- This is similar to the variance observed between the
tion that the Env protein of this virus mediates a Vb7- other HERV-K10-like clones isolated from genomic DNA
biased Sag effect on lymphocytes irrespective of their (LoÈ wer et al., 1995), which is markedly less than that
HLA phenotype (Conrad et al., 1997). In that report, the observed in env genes of other RNA viruses. Further-
onset of diabetes appeared to coincide with a demon- more, it is unlikely that IDDMK1,222 is a functional virus
strable IDDMK1,222 viremia that was not detected in con- as it has type 1 HERV-K genome with a 292-nucleotide
trols. We tried to confirm this latter finding in view of its deletion at the pol±env boundary (LoÈ wer et al., 1995).
potential importance, but could not. Whereas expression of RNA transcripts of IDDMK1,222-
In our studies, plasma samples derived from 8 newly like proviruses appears not to have specificity for diabe-
diagnosed diabetic children of 5±15 years of age (within tes, it is conceivable that the virus could provoke a patho-
one month of their clinical diagnoses) and 4 with estab- genic immune response in an individual genetically
lished type 1 diabetes, as well as 12 age-matched nondi- predisposed to type 1 diabetes, by a Sag-mediated expan-
abetic controls, were processed using the protocol that sion of an autoreactive T cell subset, or by other mecha-
Conrad et al. described in their epidemiological study nisms. To evaluate whether patients with type 1 diabetes
(Conrad et al., 1997). The Southern blot of the reverse- produced an immune response to IDDMK1,222, immu-
transcribed (RT) polymerase chain reaction (PCR) prod- noblots were performed using recombinant IDDMK1,222
ucts we obtained revealed that most plasma samples env (z20 kDa of RIC clone 1) and HERV-K Gag proteins.
had evidence of LTR-flanked nucleotide sequences (Fig- Western blot studies were performed using the bacterial
ure 1A) whether they were from patients or controls. This lysates with patient sera at a 1 in 250 dilution. Seroreac-
was not unexpected in that NCBI database searches tivity to the IDDMK1,222 Env protein was observed in 8
suggest that the oligonucleotide primers used for this of 19 diabetic and 7 of 17 control patients (Figure 2C).
study could amplify a sizable proportion of the 10,000 Two of four of the authors (N. M. and M. L.) tested were
HERV-K LTRs located within the human genome (LoÈ wer found to be strongly positive for Env antibodies. Further
et al., 1996). We concluded that these RT-PCR data dilutions of patient sera to detect the highest titers of Env
could be explained if most of the plasma samples con- antibodies did not bias the findings toward the diabetic
tained either IDDMK1,222-like RNA, genomic DNA, or patients nor alter the lack of specificity of the study.
both. In order to minimize the impact of possible con- Since immunoreactivity to IDDMK1,222 proteins may
tamination with genomic DNA, all RNA samples were have been more evident prior to diagnosis of diabetes
at an earlier point in the natural histories of the patients,incubated with DNase prior to their amplification using
